title: Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma.
abstract: OBJECTIVE
  Patients with scleroderma (systemic sclerosis; SSc) can be classified into subsets based on autoantibody profile and clinical features. Specificities such as anti-Th/To and anti-fibrillarin (U3RNP) are detectable mainly by immunoprecipitation (IP), which is not widely used in clinical laboratories. We examined the autoantibody profiles and clinical manifestations in a cohort of Italian patients with SSc, focusing on anti-Th/To and anticentromere (ACA) antibodies, associated with limited cutaneous SSc (lcSSc).
  
  
  METHODS
  Sera from 216 consecutive patients with SSc were tested for ACA (by indirect immunofluorescence), antitopoisomerase I (topo I; by counterimmunoelectrophoresis), and anti-RNA polymerase III (RNAPIII; by ELISA). Forty-one sera negative for these specificities were tested by IP analysis of proteins ((35)S-methionine labeled K562 cell extract) and RNA (silver staining).
  
  
  RESULTS
  Among 216 SSc patients analyzed, anti-topo I, ACA, and anti-RNAPIII were detected in 38% (81/216), 31% (67/216) and 7% (15/216), respectively. Among 41 sera negative for ACA, anti-topo I, and anti-RNAPIII and which were tested by IP, 14 were nucleolar stain-positive. Eight out of 14 (57%) showed anti-Th/To reactivity, but no anti-U3RNP was found. In comparison with ACA-positive patients, anti-Th/To-positive patients were younger (p = 0.0046) and more commonly were male (p = 0.0006). All 8 anti-Th/To-positive and all but one ACA-positive patients had lcSSc. Interstitial lung disease (ILD) and pericarditis were more frequent in anti-Th/To-positive patients.
  
  
  CONCLUSIONS
  Anti-Th/To are common in antinucleolar antibody-positive Italian patients with SSc. Anti-Th/To and ACA patients had lcSSc, with excellent prognosis. The anti-Th/To group had frequent pericarditis and ILD, although impairment of pulmonary function appeared mild.
authors.affiliation: Rheumatology Unit, A.O. Spedali Civili, Università degli Studi, Brescia, Italy. dott.ceribelli@libero.it
authors.forename: Angela
authors.initials: A
authors.lastname: Ceribelli
authors.forename: Ilaria
authors.initials: I
authors.lastname: Cavazzana
authors.forename: Franco
authors.initials: F
authors.lastname: Franceschini
authors.forename: Paolo
authors.initials: P
authors.lastname: Airò
authors.forename: Angela
authors.initials: A
authors.lastname: Tincani
authors.forename: Roberto
authors.initials: R
authors.lastname: Cattaneo
authors.forename: Brad A
authors.initials: BA
authors.lastname: Pauley
authors.forename: Edward K L
authors.initials: EK
authors.lastname: Chan
authors.forename: Minoru
authors.initials: M
authors.lastname: Satoh
mesh_terms: D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000097:blood* / Q000276:immunology; D001323:Autoantibodies / Q000097:blood* / Q000276:immunology; D002466:Cell Nucleolus / Q000276:immunology*; D005260:Female; D006801:Humans; D007558:Italy; D008297:Male; D008875:Middle Aged; D012595:Scleroderma, Systemic / Q000097:blood / Q000276:immunology
chemical_list: D000974:Antibodies, Antinuclear; D001323:Autoantibodies